Fortress Biotech, Inc. (FBIOP)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 16.37 |
| Open | 16.38 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 16.17 - 16.86 |
| 52-week range | 6.40 - 18.73 |
| Volume | |
| Avg. volume | 10,830 |
| Market cap | 89.482M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 2.34 (14.06%) |
| Ex-dividend date | 12 Apr 2024 |
| 1y target est | N/A |
- Zacks
AquaBounty Technologies, Inc. (AQB) Reports Q1 Loss, Misses Revenue Estimates
AquaBounty Technologies (AQB) delivered earnings and revenue surprises of -7.75% and 4.60%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Insider Stock Buying Reaches US$3.06m On Fortress Biotech
In the last year, multiple insiders have substantially increased their holdings of Fortress Biotech, Inc. ( NASDAQ:FBIO...
- GuruFocus.com
Insider Buying: President, CEO & Chairman, 10% Owner ROSENWALD LINDSAY A MD Acquires 50,000 ...
On January 5, 2024, ROSENWALD LINDSAY A MD, the President, CEO & Chairman, and 10% Owner of Fortress Biotech Inc, executed a significant stock purchase, acquiring 50,000 shares of the company.
© 2024 Yahoo. All rights reserved.